Therapeutic flag Cosmetic cross-reference

Fumaric Acid

CAS 110-17-8

Fumaric Acid (CAS 110-17-8) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
6
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Fumaric Acid
CAS Number
110-17-8
UNII
88XHZ13131
InChIKey
VZCYOOQTPOCHFL-OWOJBTEDSA-N
ChEMBL ID
CHEMBL503160
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural producttherapeutic flag
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL503160 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 6 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 30000 nM 68 -
- GI50 100000 nM 55 -
- Potency 19175.82 nM 10 -
- IC50 42153.75666666667 nM 6 -
- Ki 36800 nM 2 -
Egl nine homolog 1
Enzyme
IC50 4.72 - Homo sapiens
SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
FUMARIC ACID 25389 SU MTHSPL
Fumaric Acid 25389 SU MTHSPL
fumaric acid 25389 SU MTHSPL
fumaric acid 25389 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Fumaric Acid used for in pharmaceutical contexts?

Fumaric Acid (CAS 110-17-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Fumaric Acid?

No adverse-event association or SIDER side-effect rows are rendered for Fumaric Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Fumaric Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Fumaric Acid with EU status "permitted".

What clinical phase is Fumaric Acid in?

Fumaric Acid is rendered with ChEMBL max phase 3.

What bioactivity targets are documented for Fumaric Acid?

Fumaric Acid has 6 bioactivity rows in this page query. Rendered target entries include Egl nine homolog 1.